Fig. 4From: Naringenin alters the pharmacokinetics of ranolazine in part through the inhibition of cytochrome P450 (3A4) and P-glycoproteinThe movement of ranolazine from the serosal to the mucosal side of the rat-everted ileum (n = 6) in the presence and absence of naringenin. R, ranolazine; N, naringeninBack to article page